Eledon Pharmaceuticals, Inc. (ELDN) - Stock Prices, Stock Peers & Analysis

Home
ELDN

Company Name	Eledon Pharmaceuticals, Inc.
Symbol	ELDN
Currency	USD
Price	4.35
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	259,865,955
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.52 - 5.54
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. David-Alexandre C. Gros M.D., Ph.D.
Website	https://eledon.com

An error occurred while fetching data.

About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on